Legal & General Group PLC Theseus Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$7.28 - $11.82 $3,618 - $5,874
497 Added 34.68%
1,930 $18,000
Q3 2022

Nov 14, 2022
SELL
$5.7 - $8.68 $3,015 - $4,591
-529 Reduced 26.96%
1,433 $8,000
Q2 2022

Aug 22, 2022
BUY
$5.04 - $14.05 $4,551 - $12,687
903 Added 85.27%
1,962 $11,000
Q4 2021

Feb 14, 2022
BUY
$8.98 - $20.09 $9,509 - $21,275
1,059 New
1,059 $13,000

Others Institutions Holding THRX

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email